Vonderheide RH - Search Results

1

Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention.

Vonderheide RH. Vonderheide RH. Discov Med. 2007 Aug;7(39):103-8. Discov Med. 2007. PMID: 18093471 Free article.

2

Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.

Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Vonderheide RH, et al. Clin Cancer Res. 2001 Nov;7(11):3343-8. Clin Cancer Res. 2001. PMID: 11705846

3

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.

Vonderheide RH, Schultze JL, Anderson KS, Maecker B, Butler MO, Xia Z, Kuroda MJ, von Bergwelt-Baildon MS, Bedor MM, Hoar KM, Schnipper DR, Brooks MW, Letvin NL, Stephans KF, Wucherpfennig KW, Hahn WC, Nadler LM. Vonderheide RH, et al. Cancer Res. 2001 Dec 1;61(23):8366-70. Cancer Res. 2001. PMID: 11731409

4

Telomerase as a universal tumor-associated antigen for cancer immunotherapy.

Vonderheide RH. Vonderheide RH. Oncogene. 2002 Jan 21;21(4):674-9. doi: 10.1038/sj.onc.1205074. Oncogene. 2002. PMID: 11850795 Review.

5

Universal tumor antigens as targets for immunotherapy.

Gordan JD, Vonderheide RH. Gordan JD, et al. Among authors: vonderheide rh. Cytotherapy. 2002;4(4):317-27. doi: 10.1080/146532402760271091. Cytotherapy. 2002. PMID: 12396831 Review.

6

A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy.

Vonderheide RH, June CH. Vonderheide RH, et al. Immunol Res. 2003;27(2-3):341-56. doi: 10.1385/IR:27:2-3:341. Immunol Res. 2003. PMID: 12857980 Review.

7

Targeting adult and pediatric cancers via cell-based vaccines and the prospect of activated B lymphocytes as a novel modality.

Coughlin CM, Vonderheide RH. Coughlin CM, et al. Among authors: vonderheide rh. Cancer Biol Ther. 2003 Sep-Oct;2(5):466-70. doi: 10.4161/cbt.2.5.445. Cancer Biol Ther. 2003. PMID: 14614310 Free article. Review.

8

Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.

Danet-Desnoyers GA, Luongo JL, Bonnet DA, Domchek SM, Vonderheide RH. Danet-Desnoyers GA, et al. Among authors: vonderheide rh. Exp Hematol. 2005 Nov;33(11):1275-80. doi: 10.1016/j.exphem.2005.07.011. Exp Hematol. 2005. PMID: 16263411 Free article. Clinical Trial.

9

Telomerase-based immunotherapy of cancer.

Carpenter EL, Vonderheide RH. Carpenter EL, et al. Among authors: vonderheide rh. Expert Opin Biol Ther. 2006 Oct;6(10):1031-9. doi: 10.1517/14712598.6.10.1031. Expert Opin Biol Ther. 2006. PMID: 16989585 Review.

10

Cancer-testis antigens in tumor biology and immunotherapy.

Clark CE, Vonderheide RH. Clark CE, et al. Among authors: vonderheide rh. Cancer Biol Ther. 2006 Sep;5(9):1226-7. doi: 10.4161/cbt.5.9.3343. Epub 2006 Sep 30. Cancer Biol Ther. 2006. PMID: 17021387 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters